Orange S.A. (ORA)
Euronext Paris · France · prices in EUR · close of 23 Oct 2026
Key indicators
| Last close | EUR 14.21 |
|---|---|
| 52-week range | 13.49 – 18.81 |
| Return, 1 month / 3 months | +1.0% / −12.8% |
| Return, 1 year / 3 years | +5.2% / +57.6% |
| Trend | Below its 200-day average |
| RSI (14) | 46 |
| Volatility (1 year) | 24.5% |
| Worst drawdown (1 year) | -25.0% |
| Average daily value traded | 76.41M EUR |
| Dividend yield | 5.3% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Orange is a telecommunications operator based in France. It provides mobile and fixed-line telephone services, broadband internet access and television offerings to households, along with connectivity, cloud and security services for business customers. The company also runs mobile money and network services in several countries in Africa and the Middle East, where it serves consumer and enterprise markets under the Orange brand.
The shares are listed on the Euronext Paris in France under the code ORA, and the price on this page is in euros (EUR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Orange S.A. (ORA) trades on the Euronext Paris in France. It last closed at EUR 14.21 on 23 October 2026.
Its price-based Market X-Ray is 64 out of 100 (a fair price profile), ranking 171 of 625 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 5.2% and over the last three months it fell 12.8%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Euronext Paris
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 44 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -12.8% | ||
| From 52-week high | -24.2% | ||
| Momentum | 45 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -12.8% | ||
| 6-month return | -18.7% | ||
| 12-month return, skipping the last month | 4.1% | ||
| Stability (higher is calmer) | 75 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 24.5% | ||
| Worst drawdown, 1 year (smaller is calmer) | -25.0% | ||
| Liquidity | 97 · Strong | Trades actively. | |
| Average daily value traded | 76.41M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 85 · Strong | Dividend is high and has been paid regularly. | |
| Dividend yield | 5.3% | ||
| Years with dividends | 6 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
- Income: Dividend is high and has been paid regularly.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
Returns
| 1 week | −2.5% |
|---|---|
| 1 month | +1.0% |
| 3 months | −12.8% |
| 6 months | −18.7% |
| 1 year | +5.2% |
| 3 years | +57.6% |
| 5 years | +101.3% |
Signals
| 50-day / 200-day average | 14.88 / 16.29 |
|---|---|
| Golden / death cross (60 days) | Death, 35 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.30 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 1 Dec 2026 | EUR 0.3000 |
| 11 Jun 2026 | EUR 0.4500 |
| 2 Dec 2025 | EUR 0.3000 |
| 3 Jun 2025 | EUR 0.4500 |
| 3 Dec 2024 | EUR 0.3000 |
| 4 Jun 2024 | EUR 0.4200 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Euronext Paris; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.